9am.health Raises $16M in Series A Funding


9am.health, a San Diego, CA-based virtual diabetes clinic that delivers personalized, affordable, and compassionate care directly to consumers, raised $16m in Series A funding.

The round, which brought total funding to date to nearly $20m, was co-led by 7Wire Ventures and Human Capital and included participation from new investors StartUp Health and Leaps by Bayer, and existing investors Define Ventures and Founders Fund.

The company intends to use the funds to grow its clinical and pharmacy services to include more medications and build out an ecosystem of medical device integrations and platform partners nationwide.

Founded by Frank Westermann, Anton Kittelberger, Paul Geevarghese, and Bernhard Schandl,  9am.health offers care to people living with prediabetes or type 2 diabetes. Since launching last year, the company has scaled quickly across 47 states and D.C., providing medical care, lab diagnostics, medications, and personalized treatment plans to patients across a variety of backgrounds and demographics. It now offers a comprehensive subscription-based service that includes access to at-home diagnostic lab tests, blood glucose monitoring kits and physician-prescribed medications for prediabetes, type 2 diabetes and commonly associated conditions – all delivered directly and discreetly to patients’ homes. All members get personalized treatment plans that come with access to the medical care team that can answer any patient need.